UK online investment platform SyndicateRoom announced the closure of two lift rounds, for Peptinnovate and Alert Technology. SyndicateRoom negotiated an exclusive offer with the companies, whereby its members could participate in the equity rounds. Pekama closed its round in overfunding over the weekend. Peptinnovate, a drug development company developing animmune regulating therapy for asthma, raised £2.7 million, Alert achieved £1 million and Pekama secured £600,000. Funds from all three rounds bring the total value of all three raises to £4.3 million.
“We’re seeing an ever-increasing number of companies coming to the SyndicateRoom platform for lift rounds and overfunding,” observed SyndicateRoom CEO and founder Gonçalo de Vasconcelos. “These ‘top-ups’ are attractive to investors as they carry the certainty that the funding round is already complete and has had strong interest from others. There is also a real benefit to companies as they are able to extend the amount of capital raised quickly and easily via the platform. Importantly, we’re offering choice, for both members and entrepreneurs.”
Lead investor and equity funding scheme Discovery Park Technology Investments LP contributed to each round. Managed by NCL Innovation and supported by Kent County Council and the Regional Growth Fund, the company is committed to helping cutting-edge science and technology firms get their products or treatments to market.
“Peptinnovate’s products have the ability to significantly advance the control and management of moderate to severe chronic inflammatory diseases, with the potential for immune regulation and remission,” explained Peptinnovate CEO Richard Nagle. “We wanted to raise additional capital to accelerate the development of our lead asset through clinical trials.”
Alert Technology has developed a portable real-time warning device which help minimize the risk of unintentional exposure to deadly airborne asbestos fibers in workplaces. The device, named ALERT, is ALERT is said to be the world’s first warning device able to distinguish between asbestos and non-asbestos fibers.
“Despite the fact that asbestos is a category one human carcinogen with no safe level of exposure, disease caused by asbestos is a global and growing issue. Included in more than 3,500 products around the world, asbestos affects a wide range of industries, from all types of construction through the schools and government buildings,” shared Alert Technology Founder and Managing Director Alan Archer. “We were looking for a sophisticated investment platform which connect us to ambitious investors and SyndicateRoom has provided just that.”
Finally, the legal tech company Pekama also closed an overfunding round with SyndicateRoom. Pekama’s digital platform connects lawyers from different jurisdictions all over the world, providing them with the data they need to make decisions to optimise revenue streams, helping them build a more sustainable, and profitable, business. For more information about all three rounds, click here.
Have a crowdfunding offering you'd like to share? Submit an offering for consideration using our Submit a Tip form and we may share it on our site!